Spain Assures it Has Enough Remdesivir Stocks to Last Until October

The Ministry of Health in Spain has assured it has enough stocks of Remdesivir to treat seriously ill patients with Covid-19 until next October.

By the time the stocks run out, the company that manufactures the drug will already have new doses of the treatment available. This is one of the few medicines that has shown to be effective when fighting against the coronavirus.

 María Jesús Lamas, the director of the Spanish Agency for Medicines and Health Products, has confirmed this reserve of stocks after news hit that the United States (the country worst affected by the pandemic worldwide) had purchased the majority of the remaining Remdesivir stocks.

Gilead, the manufacturer of this COVID wonder drug, estimates, that there will be more treatments available around October, which is when the new production of the drug is ready.

A spokesperson has assured that any patients in Spain who have needed access to the drug have had access to it.

Author badge placeholder
Written by

Laura Taylor

Laura Taylor is a graduate from the University of Leeds. At university, she obtained a Bachelors in Communication and Media, as well as a Masters in International Relations.
She is half British and half Spanish and resides in Malaga. Her focus when writing news typically encompasses national Spanish news and local news from the Costa del Sol.

Share your story with us by emailing, by calling +34 951 38 61 61 or by messaging our Facebook page